Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Actinium Pharmaceuticals Inc For Securities FraudAccesswire • 5h
Actinium Pharmaceuticals Announces Publication of Results from the Phase 3 SIERRA Trial of Iomab-B in the Journal of Clinical OncologyPRNewsWire • 8h
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNMAccesswire • Thursday
The Schall Law Firm Is Looking Into Actinium Pharmaceuticals, Inc.'s Possible Securities Law Violations And Stockholders With Losses Should Reach OutAccesswire • Thursday
Actinium Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Invited To Contact The Schall Law FirmAccesswire • Wednesday
The Schall Law Firm Seeks Shareholder Participation In An Inquiry Into Actinium Pharmaceuticals, Inc. For Violating Securities LawsAccesswire • Tuesday
Actinium Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law FirmAccesswire • Monday
The Schall Law Firm Wants Shareholders To Partake In An Inquiry Into Actinium Pharmaceuticals, Inc. For Securities Related InfractionsAccesswire • 09/15/24
Actinium Pharmaceuticals Inc Is Being Investigated By The Schall Law Firm For Possible Fraud And Investors With Losses Should Reach OutAccesswire • 09/14/24
Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry In Actinium Pharmaceuticals, Inc. For Securities Law ViolationsAccesswire • 09/13/24
The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc Committed Securities Fraud And Investors With Losses Can Reach OutAccesswire • 09/12/24
Stakeholders In Actinium Pharmaceuticals Inc. Are Encouraged To Contribute To The Schall Law Firm's InquiryAccesswire • 09/11/24
IBA's joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 productionGlobeNewsWire • 09/11/24
Actinium Pharmaceuticals Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Help With An InvestigationAccesswire • 09/10/24
Shareholders Are Encouraged To Join The Schall Law Firm In An Inquiry Into Whether Actinium Pharmaceuticals, Inc. Committed Securities FraudAccesswire • 09/09/24
Securities Laws May Have Been Violated By Actinium Pharmaceuticals Inc And The Schall Law Firm Invites Investors To Join An InvestigationAccesswire • 09/07/24
Actinium Pharmaceuticals, Inc. Might Have Committed Securities Fraud And Impacted Stockholders Can Partake In The Schall Law Firm's InquiryAccesswire • 09/06/24
Investors are Invited To Join The Schall Law Firm In An Investigation Into Actinium Pharmaceuticals Inc's Potential Securities Related InfractionsAccesswire • 09/05/24
Actinium Pharmaceuticals Inc. Is Being Looked Into By The Schall Law Firm For Violating Securities Related Laws And Shareholders Should Reach OutAccesswire • 09/04/24
Investors With Losses In Actinium Pharmaceuticals Inc Are Urged To Contact The Schall Law Firm About A Securities Fraud InquiryAccesswire • 09/03/24
The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc. Violated Securities Regulations And Stockholders Should Reach OutAccesswire • 09/02/24
Actinium Pharmaceuticals Inc May Have Committed Securities Related Infractions And Investors Are Invited To Participate In The Schall Law Firm's InquiryAccesswire • 09/01/24
Shareholders Who Have Been Affected By Actinium Pharmaceuticals Inc.'s Possible Securities Law Violations Should Join The Schall Law Firm's InvestigationAccesswire • 08/31/24
Actinium Pharmaceuticals Inc May Have Committed Securities Fraud And The Schall Law Firm Wants Impacted Investors To Reach Out About An InquiryAccesswire • 08/30/24
The Public Is Urged To Join The Schall Law Firm In Investigating Actinium Pharmaceuticals Inc. For Possible Securities Law ViolationsAccesswire • 08/29/24